HHS policy on Rx costs
Executive Summary
HHS says it does not have a formal task force looking at prescription drug costs, but does consider the issue regularly. FDA Deputy Commissioner Lester Crawford, PhD, said during a House Ag Appropriations hearing that an HHS task force was examining Rx cost containment issues (11"The Pink Sheet" March 25, p. 10)...
You may also be interested in...
HHS Rx Cost-Containment Task Force Headed By Deputy Secretary Allen
HHS Deputy Secretary Claude Allen is heading a task force to examine prescription drug costs
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.